BioSpace News Archive

Roivant Sciences today named EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, a preferred provider of commercial services worldwide

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced today it is granting $380,000 in extension funding to the California Parkinson’s Disease Registry (CPDR) to be used through June 30, 2021 . The investment comes after Governor Gavin Newsom signed a bill to extend the registry by one year. The CPDR was created i

The integration of Grifols PharmacyKeeper and clinical education resources from TRC Healthcare will help pharmacy leaders by delivering the most current and relevant evidence-based education available

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020, at 1:30 p.m. PT (4:30 p.m. ET).

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced financial results and a corporate update for the quarter ended September 30, 2020.

ENDRA Life Sciences Inc. today announced that Rocky Vista University College of Osteopathic Medicine (“RVUCOM”) has begun scanning patients in its clinical study of ENDRA’s Thermo-Acoustic Enhanced Ultrasound

Advent Technologies, an innovation-driven company in the fuel cell and hydrogen technology space, today announced the appointment of Katherine E. Fleming as a new Member of its Board of Directors, in the context of its planned merger with AMCI Acquisition Corp (NASDAQ: AMCI) and the upcoming Nasdaq listing. Advent has recently announced a definitive agreement to merge with AMCI Acquisition

Protara Therapeutics Announces Third Quarter 2020 Financial Results and Business Overview

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today reports its financial results for the third quarter ended September 30, 2020 and provides a corporate update. “The third quarter saw continued advancement and validation of our clinical development programs, with a focus on our oncology pipeline of replicating arenavirus-based

LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has added Ryan Montecucco as General Counsel and Secretary. “We are very pleased to have Ryan join our team,” stated Clark Tedford , Ph.D., President and CEO. “Ryan has been